BioCentury
ARTICLE | Financial News

Impact raises $10M in series B

February 23, 2016 2:39 AM UTC

Cancer play Impact Therapeutics Inc. (Nanjing, China) said it raised about $10 million in a series B round that included new investors China Summit Capital, Guangzhou Yuexiu Industrial Investment Fund, Sungent Bioventure, and Haibang Ventures. Existing investor Lilly Asia Ventures also participated. ...